Do Raw Onions Boost Testosterone?
No, raw onions should not be relied upon to meaningfully increase testosterone levels in men, and they are not a substitute for evidence-based medical treatment of hypogonadism.
While animal studies suggest onions may enhance testosterone through mechanisms like increased luteinizing hormone production and antioxidant effects, no human clinical trials have confirmed these findings 1. The evidence base consists entirely of rodent experiments, which cannot be extrapolated to clinical practice 1, 2, 3, 4, 5.
Evidence from Animal Studies (Not Applicable to Humans)
Rodent Research Findings
Fresh onion juice increased serum testosterone levels in male rats through multiple proposed mechanisms: enhancing luteinizing hormone production, improving testicular antioxidant defenses, neutralizing free radicals, ameliorating insulin resistance, and promoting nitric oxide production 1.
In sexually potent male rats, onion juice administration reduced mount latency, increased copulatory efficacy, and elevated serum testosterone 2.
Rats receiving onion extract equivalent to 0.5–1 g/rat/day showed significantly increased testosterone, improved sperm viability and motility, and elevated LH (at higher doses only) 3.
Onion extract protected against dexamethasone-induced testicular damage in rats by normalizing testosterone, glutathione, and antioxidant activity 4.
Cysteine sulfoxides (unique amino acids in onions) enhanced progesterone production—a testosterone precursor—in mouse testis-derived tumor cells via protein kinase A pathway activation 5.
Critical Limitation
These are exclusively animal studies with no human validation 1. The authors themselves acknowledge that "this effect requires further approval in humans, mainly by conducting clinical trials" 1. Rodent physiology, hormone regulation, and dietary metabolism differ fundamentally from humans, making direct translation inappropriate.
Evidence-Based Approach to Low Testosterone
If you suspect low testosterone, the correct approach is not dietary supplementation with onions but rather:
Diagnostic Confirmation
Obtain two separate fasting morning (8–10 AM) total testosterone measurements; both must be <300 ng/dL to confirm hypogonadism 6.
Measure LH and FSH after confirming low testosterone to distinguish primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism 6.
In borderline cases (231–346 ng/dL) or obese patients, measure free testosterone by equilibrium dialysis and sex hormone-binding globulin (SHBG) 6.
Symptom Assessment
Testosterone therapy is justified only for diminished libido and/or erectile dysfunction as primary symptoms 6.
Nonspecific complaints (fatigue, low energy, mood changes) do not respond meaningfully to testosterone replacement, even when hypogonadism is confirmed 6.
Treatment Options
Transdermal testosterone gel (1.62%, ~40 mg daily) is first-line due to stable serum levels and lower erythrocytosis risk (15% vs. 44% with injectables) 6.
Intramuscular testosterone cypionate/enanthate (100–200 mg every 2 weeks) is a cost-effective alternative but carries higher erythrocytosis risk 6.
Target mid-normal testosterone levels (450–600 ng/dL) during monitoring 6, 7.
For men desiring fertility preservation: gonadotropin therapy (hCG + FSH) is mandatory; testosterone is absolutely contraindicated because it causes prolonged azoospermia 6.
Expected Outcomes
Testosterone therapy produces a small but statistically significant improvement in sexual function (standardized mean difference ≈0.35) 6.
There is little to no effect on energy, vitality, physical functioning, depressive symptoms, or cognition 6.
Monitoring Requirements
Check testosterone, hematocrit, and PSA (men >40 years) at 2–3 months, then every 3–6 months during year one, then annually 6, 8.
Withhold therapy if hematocrit exceeds 54% and consider therapeutic phlebotomy 6.
Refer to urology if PSA rises >1.0 ng/mL within 6 months or >0.4 ng/mL per year thereafter 6.
Why Dietary Approaches Are Insufficient
Reversible Causes Should Be Addressed First
Obesity-associated secondary hypogonadism is the most common reversible cause in middle-aged men; excess adipose tissue increases aromatization of testosterone to estradiol, suppressing LH 6.
Weight loss through hypocaloric diets (500–750 kcal/day deficit) and structured exercise (≥150 min/week moderate-intensity aerobic activity plus resistance training 2–3 times/week) can significantly increase endogenous testosterone production 6.
A 5–10% weight loss can markedly improve testosterone levels without medication 6.
Other Reversible Factors
Metabolic syndrome and type 2 diabetes directly impair testicular testosterone synthesis 6.
Chronic medications (opioids, glucocorticoids, anabolic steroids) suppress the hypothalamic-pituitary axis 6.
Hyperprolactinemia, hypothyroidism, obstructive sleep apnea, and chronic inflammatory states all contribute to secondary hypogonadism 6.
Common Pitfalls to Avoid
Do not diagnose hypogonadism on a single testosterone measurement or symptoms alone; require two morning values <300 ng/dL plus specific sexual symptoms 6.
Do not attribute low testosterone solely to age in men under 50; prioritize evaluation for obesity, diabetes, medication effects, and other reversible factors 6.
Do not initiate testosterone without confirming the patient does not desire fertility, as therapy causes prolonged azoospermia 6.
Do not prescribe testosterone for weight loss, general energy enhancement, or athletic performance; these are not evidence-based indications 6.
Do not rely on unproven dietary supplements (including onions) when evidence-based medical treatments exist 1.
Cardiovascular Safety of Testosterone Therapy
The TRAVERSE trial (2023) enrolled 5,246 men ages 45–80 with confirmed hypogonadism and pre-existing or high cardiovascular risk; transdermal testosterone gel showed no significant increase in major adverse cardiac events or non-fatal stroke compared with placebo over 21.7 months 9.
Current consensus supports that testosterone therapy, when prescribed to appropriately selected patients and monitored regularly, is safe from a cardiovascular standpoint 9.